Skip to main content

Alphabet Inc.

13F filer · CIK 0001652044
Reported Aug 7, 2026
Net buyer this quarter
13F portfolio value$99.1BU.S. long equity reported on 13F
Positions283 new · 1 closed
Net flow last quarter+$94.3BBuys minus sells
Top 10 positions weight99.5%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 7, 202628 positions
SPCXSpace Exploration Technologies Corp$94.2B95.05%Not reportedNewQ2 2026
PLPlanet Labs PBC$1.17B1.18%13.55%Not reportedQ4 2021
ASTSAST SpaceMobile, Inc.$795M0.80%Not reportedNot reportedQ1 2025
CMECme Group Inc.$769M0.78%1.05%Not reportedQ1 2026
ARMArm Holdings PLC$695M0.70%0.18%Not reportedQ3 2023
RVMDRevolution Medicines, Inc.$552M0.56%1.38%-10.5%Q4 2023
FRSHFreshworks Inc.$164M0.17%10.53%Not reportedQ4 2021
PBLSParabilis Medicines, Inc.$135M0.14%4.03%NewQ2 2026
TEMTempus AI, Inc.$89.9M0.09%Not reportedNot reportedQ2 2024
GTLBGitlab Inc.$83.2M0.08%Not reportedNot reportedQ2 2022
PATHUiPath, Inc.$76.5M0.08%Not reportedNot reportedQ2 2021
LIFEEthos Technologies Inc.$65.7M0.07%21.76%-3.9%Q1 2026
PRMEPrime Medicine, Inc.$61.1M0.06%9.16%Not reportedQ4 2022
FRVOFervo Energy Co$51.5M0.05%Not reportedNewQ2 2026
PAYPPayPay Corp$44.8M0.05%0.46%Not reportedQ1 2026
MAZEMaze Therapeutics, Inc.$41.4M0.04%2.50%Not reportedQ1 2025
RLAYRelay Therapeutics, Inc.$26.4M0.03%0.65%-9.9%Q3 2020
BBOTBridgeBio Oncology Therapeutics, Inc.$21.5M0.02%3.52%Not reportedQ3 2025
OSCROscar Health, Inc.$13.7M0.01%Not reportedNot reportedQ1 2021
BEAMBeam Therapeutics Inc.$11M0.01%0.31%Not reportedQ1 2020
VERAVera Therapeutics, Inc.$10.4M0.01%0.34%Not reportedQ2 2021
SANASana Biotechnology, Inc.$9.82M0.01%0.94%Not reportedQ1 2021
GLUEMonte Rosa Therapeutics, Inc.$9.01M0.01%0.44%-45.6%Q2 2021
LYELLyell Immunopharma, Inc.$4.12M0.00%1.25%Not reportedQ2 2021
FIGFigma, Inc.$3.9M0.00%Not reportedNot reportedQ3 2025
SPROSpero Therapeutics, Inc.$1.97M0.00%1.53%Not reportedQ4 2017
HYPRHyperfine, Inc.$1.21M0.00%Not reportedNot reportedQ4 2021
AUTLAutolus Therapeutics plc$1.12M0.00%0.26%Not reportedQ2 2018
Q1 2026Reported May 8, 202626 positions
CMECme Group Inc.$1.03B25.63%1.05%NewQ1 2026
PLPlanet Labs PBC$985M24.53%13.55%+10.4%Q4 2021
ASTSAST SpaceMobile, Inc.$741M18.46%Not reportedNot reportedQ1 2025
RVMDRevolution Medicines, Inc.$320M7.97%1.64%-1.6%Q4 2023
ARMArm Holdings PLC$297M7.39%0.18%Not reportedQ3 2023
FRSHFreshworks Inc.$130M3.24%10.53%Not reportedQ4 2021
PATHUiPath, Inc.$78.1M1.94%Not reportedNot reportedQ2 2021
TEMTempus AI, Inc.$70.1M1.75%Not reportedNot reportedQ2 2024
PAYPPayPay Corp$66.7M1.66%0.46%NewQ1 2026
GTLBGitlab Inc.$59M1.47%Not reportedNot reportedQ2 2022
PRMEPrime Medicine, Inc.$57.6M1.44%9.17%Not reportedQ4 2022
LIFEEthos Technologies Inc.$42.1M1.05%22.65%NewQ1 2026
MAZEMaze Therapeutics, Inc.$41.4M1.03%2.79%Not reportedQ1 2025
BBOTBridgeBio Oncology Therapeutics, Inc.$25.3M0.63%3.53%Not reportedQ3 2025
RLAYRelay Therapeutics, Inc.$15.6M0.39%0.83%-0.3%Q3 2020
GLUEMonte Rosa Therapeutics, Inc.$11.3M0.28%0.81%-8.1%Q2 2021
VERAVera Therapeutics, Inc.$9.71M0.24%0.38%Not reportedQ2 2021
SANASana Biotechnology, Inc.$8.1M0.20%1.04%Not reportedQ1 2021
BEAMBeam Therapeutics Inc.$7.66M0.19%0.31%Not reportedQ1 2020
LYELLyell Immunopharma, Inc.$5.88M0.15%1.26%Not reportedQ2 2021
OSCROscar Health, Inc.$5.53M0.14%Not reportedNot reportedQ1 2021
FIGFigma, Inc.$4.56M0.11%Not reportedNot reportedQ3 2025
SPROSpero Therapeutics, Inc.$2.08M0.05%1.54%Not reportedQ4 2017
HYPRHyperfine, Inc.$971K0.02%Not reportedNot reportedQ4 2021
AUTLAutolus Therapeutics plc$964K0.02%0.26%Not reportedQ2 2018
TNYATenaya Therapeutics, Inc.$632K0.02%0.42%Not reportedQ3 2021
Q4 2025Reported Feb 13, 202629 positions
ASTSAST SpaceMobile, Inc.$650M25.18%Not reportedNot reportedQ1 2025
PLPlanet Labs PBC$630M24.42%12.28%Not reportedQ4 2021
RVMDRevolution Medicines, Inc.$266M10.33%1.70%-19.1%Q4 2023
ARMArm Holdings PLC$214M8.31%0.18%Not reportedQ3 2023
FRSHFreshworks Inc.$199M7.70%10.53%Not reportedQ4 2021
PATHUiPath, Inc.$115M4.47%Not reportedNot reportedQ2 2021
GTLBGitlab Inc.$102M3.96%Not reportedNot reportedQ2 2022
TEMTempus AI, Inc.$91.6M3.55%Not reportedNot reportedQ2 2024
DXCMDexcom Inc$68.8M2.67%0.27%Not reportedQ4 2018
MAZEMaze Therapeutics, Inc.$57.5M2.23%2.81%-42.4%Q1 2025
PRMEPrime Medicine, Inc.$57.5M2.23%9.18%Not reportedQ4 2022
BBOTBridgeBio Oncology Therapeutics, Inc.$35.3M1.37%3.53%Not reportedQ3 2025
RLAYRelay Therapeutics, Inc.$13.3M0.51%0.90%Not reportedQ3 2020
VERAVera Therapeutics, Inc.$12.2M0.47%0.38%Not reportedQ2 2021
GLUEMonte Rosa Therapeutics, Inc.$11.7M0.45%1.14%-49.1%Q2 2021
SANASana Biotechnology, Inc.$11.4M0.44%1.05%Not reportedQ1 2021
LYELLyell Immunopharma, Inc.$9.03M0.35%1.38%Not reportedQ2 2021
BEAMBeam Therapeutics Inc.$8.91M0.35%0.32%Not reportedQ1 2020
FIGFigma, Inc.$8.06M0.31%Not reportedNot reportedQ3 2025
OSCROscar Health, Inc.$6.93M0.27%Not reportedNot reportedQ1 2021
WGSGeneDx Holdings Corp.$2.95M0.11%0.08%Not reportedQ3 2024
EXKEndeavour Silver Corp$2.36M0.09%0.01%Not reportedQ3 2021
SPROSpero Therapeutics, Inc.$2.07M0.08%1.58%Not reportedQ4 2017
AUTLAutolus Therapeutics plc$1.39M0.05%0.26%Not reportedQ2 2018
HYPRHyperfine, Inc.$881K0.03%Not reportedNot reportedQ4 2021
TNYATenaya Therapeutics, Inc.$650K0.03%0.42%Not reportedQ3 2021
QNCXQuince Therapeutics, Inc.$634K0.02%67.88%Not reportedQ2 2019
FULCFulcrum Therapeutics, Inc.$161K0.01%0.02%Not reportedQ3 2019
RGENRepligen Corp$62.8K0.00%0.00%Not reportedQ4 2021
Q3 2025Reported Nov 7, 202537 positions
ASTSAST SpaceMobile, Inc.$439M18.22%Not reportedNot reportedQ1 2025
PLPlanet Labs PBC$415M17.21%12.28%Not reportedQ4 2021
ARMArm Holdings PLC$277M11.52%0.18%Not reportedQ3 2023
MTSRMetsera, Inc.$198M8.22%3.60%-23.8%Q1 2025
RVMDRevolution Medicines, Inc.$193M8.01%2.18%Not reportedQ4 2023
FRSHFreshworks Inc.$191M7.92%10.53%Not reportedQ4 2021
TEMTempus AI, Inc.$125M5.20%Not reportedNot reportedQ2 2024
GTLBGitlab Inc.$123M5.10%Not reportedNot reportedQ2 2022
PATHUiPath, Inc.$94.1M3.91%Not reportedNot reportedQ2 2021
PRMEPrime Medicine, Inc.$91.8M3.81%9.19%+10.0%Q4 2022
DXCMDexcom Inc$69.8M2.90%0.27%Not reportedQ4 2018
MAZEMaze Therapeutics, Inc.$62.6M2.60%5.02%Not reportedQ1 2025
BBOTBridgeBio Oncology Therapeutics, Inc.$32.7M1.36%3.56%NewQ3 2025
FIGFigma, Inc.$11.2M0.46%Not reportedNewQ3 2025
GLUEMonte Rosa Therapeutics, Inc.$10.8M0.45%2.37%Not reportedQ2 2021
SANASana Biotechnology, Inc.$9.98M0.41%1.07%Not reportedQ1 2021
OSCROscar Health, Inc.$9.12M0.38%Not reportedNot reportedQ1 2021
DNTHDianthus Therapeutics, Inc.$8.21M0.34%0.49%Not reportedQ3 2023
RLAYRelay Therapeutics, Inc.$8.19M0.34%0.91%Not reportedQ3 2020
BEAMBeam Therapeutics Inc.$7.81M0.32%0.32%Not reportedQ1 2020
VERAVera Therapeutics, Inc.$7.01M0.29%0.38%Not reportedQ2 2021
LYELLyell Immunopharma, Inc.$4.76M0.20%1.52%Not reportedQ2 2021
FHTXFoghorn Therapeutics Inc.$2.45M0.10%0.89%Not reportedQ4 2020
WGSGeneDx Holdings Corp.$2.45M0.10%0.08%Not reportedQ3 2024
TSHATaysha Gene Therapies, Inc.$2.1M0.09%0.23%Not reportedQ3 2020
TCRXTScan Therapeutics, Inc.$1.96M0.08%4.49%Not reportedQ3 2021
BRNSBarinthus Biotherapeutics plc.$1.89M0.08%3.71%Not reportedQ2 2021
SPROSpero Therapeutics, Inc.$1.67M0.07%1.58%Not reportedQ4 2017
TNYATenaya Therapeutics, Inc.$1.48M0.06%0.56%Not reportedQ3 2021
HYPRHyperfine, Inc.$1.3M0.05%Not reportedNot reportedQ4 2021
EXKEndeavour Silver Corp$1.27M0.05%0.01%Not reportedQ3 2021
AUTLAutolus Therapeutics plc$1.14M0.05%0.26%Not reportedQ2 2018
GUTSFractyl Health, Inc.$1.05M0.04%0.50%Not reportedQ1 2024
ALECAlector, Inc.$521K0.02%0.16%Not reportedQ1 2019
QNCXQuince Therapeutics, Inc.$308K0.01%0.35%Not reportedQ2 2019
FULCFulcrum Therapeutics, Inc.$131K0.01%0.03%Not reportedQ3 2019
RGENRepligen Corp$51.2K0.00%0.00%Not reportedQ4 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.